Predictive Oncology, Inc. Announces Initiation of Equity Analyst Coverage by H.C. Wainwright “The initiation of coverage by H.C. Wainwright marks a milestone in our efforts to be independently valued by such a highly respected analyst with specialized knowledge and critical insights into our competitive standing and growth potential,” said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. “We are grateful for this recognition and very pleased with H.C. Wainwrights ‘Buy’ recommendation.” Learn more here: https://lnkd.in/gRv5RWvZ
Predictive Oncology’s Post
More Relevant Posts
-
Director of Client Services | Accelerating the Value of the MEDITECH EHR | Abbott World Marathon Majors Six-Star Finisher
If you are a MEDITECH #Expanse healthcare organization that is considering implementing the Oncology (ONC) module, you owe it to yourself to read this article by Haffty Consulting's own Ann Walsh, a leading clinical consultant with years of ONC experience.
Ann Walsh shared her experience collaborating with clients on implementing MEDITECH’s Oncology solution across platforms and the benefits of MEDITECH Expanse as an Integrated Oncology solution on the Haffty Consulting site at https://lnkd.in/gUAmndgp
-
-
While oncology has been the dominating therapy area in the industry R&D pipeline, #CNS is gaining momentum, accounting for 10% of the industry R&D pipeline and ranking the second largest therapeutic area behind oncology. Discover why, here: https://bit.ly/40cLsmz
-
-
Work smarter and boost the profitability of your oncology practice. Oncology Convergence offers Oncology Revenue Cycle Management services to help you simplify management so you can focus on your patients. Learn more about us and how we can help you overcome obstacles and succeed: https://bit.ly/3TxrcW2
-
-
In the latest Applied Clinical Trials Magazine article by our Matt Cooper and james eamma, they explore how the FDA's Project Optimus guidance will shape the future of oncology studies and impact sponsors' clinical decisions. The sooner sponsors operationalize these recommendations, the better their position will be. Act now and check out the key strategies for success to prepare your clinical programs as leaders in this new era of oncology! https://ow.ly/rzcr50TBjFF
-
-
Work smarter and boost the profitability of your oncology practice. Oncology Convergence offers Oncology Revenue Cycle Management services to help you simplify management so you can focus on your patients. Learn more about us and how we can help you overcome obstacles and succeed: https://bit.ly/3TxrcW2
-
-
If you are evaluating MEDITECH Oncology or have a different oncology solution which you integrate with MEDITECH Expanse, Ann Walsh's article on MEDITECH Expanse as an Integrated Oncology Solution will be insightful. Ann’s article is at https://lnkd.in/gUAmndgp
-
-
Download our latest insight brief with Gerhard du Toit, Global Oncology Head at IQVIA Biotech, and learn how global oncology trends are impacting clinical trial strategy in early phase oncology, platform design trials, and diversity planning. Download now. https://bit.ly/3SzFc2A #oncology #clinicaltrials #earlyphaseoncology
-
Work smarter and boost the profitability of your oncology practice. Oncology Convergence offers Oncology Revenue Cycle Management services to help you simplify management so you can focus on your patients. Learn more about us and how we can help you overcome obstacles and succeed: https://bit.ly/3TxrcW2
-
-
Download our latest insight brief with Gerhard du Toit, Global Oncology Head at IQVIA Biotech, and learn how global oncology trends are impacting clinical trial strategy in early phase oncology, platform design trials, and diversity planning. Download now. https://bit.ly/3vZf4qA #oncology #clinicaltrials #earlyphaseoncology
Sharing strategies to streamline complex clinical programs.
iqviabiotech.com
-
#JAPAC #MarketAccess #IndianGenerics JAPAC is a market of interest, reach out to us to understand how #IQVIA can support this journey Anand Maheshwari Rahul Taneja Gaurav Pokharna Govind MK Swati Chaudhary
Join us for an in-depth webinar on the latest #FDAinitiatives, including #ProjectOptimus and Project FrontRunner, and their implications for JAPAC #biopharma. Delve into the evolving regulatory landscape, early-phase oncology, and #clinicaldevelopment strategies that are shaping global expansion. Explore oncology case studies and gain valuable insights into how these initiatives are driving innovation and excellence in the field. Don't miss this opportunity to stay ahead in the rapidly changing world of oncology. Register today: https://lnkd.in/gY4jQAp2
